Management of therapy-resistant rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Baillière's Best Practice & Research : Clinical Rheumatology

• Publication date

  1999-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/BERH.1999.0057PMID 10652651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Extra-articular manifestations of rheumatoid arthritis].

  2000cited by this paper
• Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.

  1998cited by this paper
• Treatment of refractory rheumatoid arthritis with low-dose cyclophosphamide. Long-term follow-up of 108 patients

  1998cited by this paper
• Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

  1998cited by this paper
• Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.

  1998cited by this paper
• Rheumatoid arthritis of the cervical spine.

  1998cited by this paper
• Combination therapy in rheumatoid arthritis: updated systematic review.

  1998cited by this paper
• Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes. A mechanism for methotrexate‐induced nodulosis in rheumatoid arthritis

  1997cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

  1997cited by this paper
• Progression of cervical spine changes in patients with early rheumatoid arthritis.

  1997cited by this paper
• Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis.

  1997cited by this paper
• Yttrium-90 radiochemical synovectomy in chronic knee synovitis: a one year retrospective review of 133 treatment interventions.

  1997cited by this paper
• The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial.

  1997cited by this paper
• Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity.

  1997cited by this paper
• Humanized anti‐CD4 monoclonal antibody therapy of autoimmune and inflammatory disease

  1997cited by this paper
• Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.

  1997cited by this paper
• Arthroscopy-assisted synovectomy in the treatment of chronic synovitis of the knee.

  1997cited by this paper
• Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee.

  1997cited by this paper
• Radiochemical synovectomy.

  1997cited by this paper
• Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers.

  1996cited by this paper
• Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.

  1996cited by this paper
• Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases.

  1996cited by this paper
• Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.

  1996cited by this paper
• Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.

  1996cited by this paper
• Sjögren's syndrome revisited: autoimmune epithelitis.

  1996cited by this paper
• The mortality of rheumatoid vasculitis compared with rheumatoid arthritis.

  1996cited by this paper
• Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic Markers

  1996cited by this paper
• Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis.

  1996cited by this paper
• Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.

  1996cited by this paper
• Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

  1996cited by this paper
• Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis.

  1996cited by this paper
• CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.

  1996cited by this paper
• Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial.

  1996cited by this paper
• Cervical spine surgery in patients with rheumatoid arthritis: an appraisal.

  1996cited by this paper
• High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy.

  1996cited by this paper
• Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis: the effect on lymphocytes.

  1996cited by this paper
• Initial experience combining methotrexate with biologic agents for treating rheumatoid arthritis.

  1996cited by this paper
• Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

  1996cited by this paper
• A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans

  1996cited by this paper
• Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.

  1996cited by this paper
• A survey of radiation synovectomy in Europe, 1991–1993

  1995cited by this paper
• Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.

  1995cited by this paper
• Pulmonary involvement in rheumatoid arthritis.

  1995cited by this paper
• Non-surgical synovectomy

  1995cited by this paper
• Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection.

  1995cited by this paper
• Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension.

  1995cited by this paper
• Immunology of systemic rheumatoid disease.

  1995cited by this paper
• Innovative treatment approaches for rheumatoid arthritis. Non-surgical synovectomy.

  1995cited by this paper
• CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.

  1995cited by this paper
• The use of sandimmun® (cyclosporin A) in severe refractory rheumatoid arthritis: The Belgian experience

  1995cited by this paper
• Long-Term Usage and Side-Effect Profile of Sulphasalazine in Rheumatoid Arthritis

  1995cited by this paper
• Current management of cervical spine instability.

  1995cited by this paper
• Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

  1995cited by this paper
• Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.

  1995cited by this paper
• Extraarticular Manifestations of Rheumatoid Arthritis

  1995cited by this paper
• A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis.

  1995cited by this paper
• Atlanto-occipital subluxation in rheumatoid arthritis demonstrated by magnetic resonance imaging.

  1995cited by this paper
• An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.

  1995cited by this paper
• Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial.

  1994cited by this paper
• Methotrexate-related pulmonary complications in rheumatoid arthritis.

  1994cited by this paper
• Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: A controlled 6-month clinical trial

  1994cited by this paper
• [Radiation synovectomy with yttrium 90 and rhenium 186 in rheumatoid arthritis, long term follow-up and effects on synovial membrane].

  1994cited by this paper
• Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1.

  1994cited by this paper
• Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.

  1994cited by this paper
• Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts.

  1994cited by this paper
• Long-term methotrexate in refractory rheumatoid arthritis; concurrent use of prednisone possibly improves drug-survival

  1994cited by this paper
• [Treatment of refractory rheumatoid arthritis with cyclosporine].

  1994cited by this paper
• Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).

  1994cited by this paper
• Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trial.

  1994cited by this paper
• Efficacy and safety of radiation synovectomy with Yttrium-90: a retrospective long-term analysis of 164 applications in 82 patients.

  1993cited by this paper
• Lung involvement in rheumatoid factor-negative arthritis.

  1993cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

  1993cited by this paper
• Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis.

  1993cited by this paper
• Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.

  1993cited by this paper
• Bronchoalveolar lavage in rheumatoid arthritis.

  1993cited by this paper
• Corticosteroid pulse therapy in active rheumatoid arthritis.

  1993cited by this paper
• Early clinical studies of IL-2 fusion toxin in patients with severe rheumatoid arthritis and recent onset insulin-dependent diabetes mellitus.

  1993cited by this paper
• Pulmonary manifestations of rheumatic disease.

  1993cited by this paper
• Experience with a chimeric monoclonal anti-CD4 antibody in the treatment of refractory rheumatoid arthritis.

  1993cited by this paper
• DAB486IL-2 fusion toxin in refractory rheumatoid arthritis.

  1993cited by this paper
• Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5)

  1992cited by this paper
• Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis.

  1992cited by this paper
• Humanised monoclonal antibody therapy for rheumatoid arthritis.

  1992cited by this paper
• Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

  1992cited by this paper
• Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis.

  1992cited by this paper
• High dose intravenous methotrexate for refractory rheumatoid arthritis.

  1992cited by this paper
• Rheumatoid nodulosis: A puzzling variant of rheumatoid arthritis

  1992cited by this paper
• Traitement de la polyarthrite rhumatoïde réfractaire par la ciclosporine

  1992cited by this paper
• PROVISIONAL GUIDELINES FOR MEASURING DISEASE ACTIVITY IN CLINICAL TRIALS ON RHEUMATOID ARTHRITIS

  1992cited by this paper
• High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.

  1992cited by this paper
• Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis.

  1991cited by this paper
• Diagnostic histopathology of major systemic and pulmonary vasculitic syndromes.

  1990cited by this paper

• Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review

  2021cites this paper
• CURRENT CLINICAL STRATEGIES IN RHEUMATOID ARTHRITIS: A REVIEW

  2012cites this paper
• Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence

  2008cites this paper
• Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.

  2007cites this paper
• The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

  2004cites this paper
• Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults

  2003cites this paper
• Contribution of patient related differences to multidrug resistance in rheumatoid arthritis

  2003cites this paper
• Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.

  2003cites this paper
• The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.

  2002cites this paper
• Pharmacotherapy of Rheumatoid Arthritis: An Overview

  2001cites this paper